ADA 2023: Bempedoic Acid Cuts Risk for Major Adverse Cardiovascular Events in Statin-Intolerant Patients
The nonstatin cholesterol-lowering drug cuts risk by one-third when used for primary prevention
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.